CVS chief: employer plans won’t cover GLP-1 weight-loss drugs yet
CVS Health’s CEO David Joyner says private employers aren’t ready to broadly cover GLP-1 weight-loss drugs like Ozempic because of high costs and uncertain long-term savings; prices need to come down and there must be clear evidence they reduce overall health care costs before broader coverage resumes, even as Medicare moves to cover GLP-1s.